197 related articles for article (PubMed ID: 25971661)
1. Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands.
Zhang Y; de Boer A; Verhoef TI; van der Meer FJ; Le Cessie S; Maitland-van der Zee AH; ;
Thromb Res; 2015 Jul; 136(1):94-100. PubMed ID: 25971661
[TBL] [Abstract][Full Text] [Related]
2. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.
Baranova EV; Verhoef TI; Ragia G; le Cessie S; Asselbergs FW; de Boer A; Manolopoulos VG; Maitland-van der Zee AH;
J Thromb Haemost; 2017 Mar; 15(3):465-472. PubMed ID: 28063245
[TBL] [Abstract][Full Text] [Related]
3. Age-stratified outcome of a genotype-guided dosing algorithm for acenocoumarol and phenprocoumon.
Zhang Y; de Boer A; Verhoef TI; van der Meer FJ; Le Cessie S; Manolopoulos VG; Maitland-van der Zee AH;
J Thromb Haemost; 2017 Mar; 15(3):454-464. PubMed ID: 27992949
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef TI; Ragia G; de Boer A; Barallon R; Kolovou G; Kolovou V; Konstantinides S; Le Cessie S; Maltezos E; van der Meer FJ; Redekop WK; Remkes M; Rosendaal FR; van Schie RM; Tavridou A; Tziakas D; Wadelius M; Manolopoulos VG; Maitland-van der Zee AH;
N Engl J Med; 2013 Dec; 369(24):2304-12. PubMed ID: 24251360
[TBL] [Abstract][Full Text] [Related]
5. Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study.
van Miert JHA; Veeger NJGM; Ten Cate-Hoek AJ; Piersma-Wichers M; Meijer K
PLoS One; 2020; 15(7):e0235639. PubMed ID: 32649714
[TBL] [Abstract][Full Text] [Related]
6. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH
J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090
[TBL] [Abstract][Full Text] [Related]
8. Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor: validation of a new algorithm.
Beinema MJ; van der Meer FJ; Brouwers JR; Rosendaal FR
J Thromb Haemost; 2016 Mar; 14(3):479-84. PubMed ID: 26712475
[TBL] [Abstract][Full Text] [Related]
9. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.
Fihn SD; Gadisseur AA; Pasterkamp E; van der Meer FJ; Breukink-Engbers WG; Geven-Boere LM; van Meegen E; de Vries-Goldschmeding H; Antheunissen-Anneveld I; van't Hoff AR; Harderman D; Smink M; Rosendaal FR
Thromb Haemost; 2003 Aug; 90(2):260-6. PubMed ID: 12888873
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The Netherlands.
Verhoef TI; Redekop WK; de Boer A; Maitland-van der Zee AH;
Pharmacogenomics; 2015 Jan; 16(2):101-14. PubMed ID: 25616097
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol.
van Schie RM; Babajeff AM; Schalekamp T; Wessels JA; le Cessie S; de Boer A; van der Meer FJ; van Meegen E; Verhoef TI; Rosendaal FR; Maitland-van der Zee AH;
J Thromb Haemost; 2012 May; 10(5):767-72. PubMed ID: 22409277
[TBL] [Abstract][Full Text] [Related]
12. Initiation of oral anticoagulant therapy in orthopedic and surgical patients: an algorithm compared with routine dosing.
van den Bemt PM; Beinema M; van Roon EN; Sijtsma J; Baars WA; Mencke HJ; Brouwers JR
Eur J Clin Pharmacol; 2002 Jun; 58(3):203-208. PubMed ID: 12162272
[TBL] [Abstract][Full Text] [Related]
13. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
14. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements.
van Geest-Daalderop JH; Péquériaux NC; van den Besselaar AM
Thromb Haemost; 2009 Sep; 102(3):588-92. PubMed ID: 19718481
[TBL] [Abstract][Full Text] [Related]
15. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Rombouts EK; Rosendaal FR; van der Meer FJ
Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
Gadisseur AP; van der Meer FJ; Adriaansen HJ; Fihn SD; Rosendaal FR
Br J Haematol; 2002 Jun; 117(4):940-6. PubMed ID: 12060134
[TBL] [Abstract][Full Text] [Related]
17. Phenprocoumon and acenocoumarol treatment in paediatric patients.
Spoor N; Smiers FJ; van der Meer FJ; Hutten BA; van Ommen CH
Thromb Haemost; 2012 Dec; 108(6):1238-41. PubMed ID: 23014894
[No Abstract] [Full Text] [Related]
18. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.
Visser LE; Penning-van Bees FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
Thromb Haemost; 2002 Nov; 88(5):705-10. PubMed ID: 12428081
[TBL] [Abstract][Full Text] [Related]
19. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
van Leeuwen Y; Rosendaal FR; van der Meer FJ
Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial.
Gadisseur AP; Breukink-Engbers WG; van der Meer FJ; van den Besselaar AM; Sturk A; Rosendaal FR
Arch Intern Med; 2003 Nov; 163(21):2639-46. PubMed ID: 14638565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
